Loading...
XASX
AVH
Market cap388mUSD
Oct 30, Last price  
4.69AUD
1D
-0.42%
1Q
260.77%
Jan 2017
118.92%
IPO
15.53%
Name

AVITA Medical Inc

Chart & performance

D1W1MN
XASX:AVH chart
P/E
—
P/S
1.14
EPS
—
Vol. 1Y
73.15%
Shs. 5Y
6.55%
Rev. 5Y
19.63%
Div Yld LY
—
Div Yld TTM
—
Revenues
72m
+11.45%
862,1091,253,2942,192,5642,807,3953,118,3433,430,6933,042,9572,855,792997,0881,342,8891,541,6691,704,6057,829,37014,263,00029,232,00033,025,00034,421,00050,143,00064,251,00071,610,000
Net income
-49m
L-21.44%
-15,066,551-12,141,907-5,179,074-5,932,407-1,950,268-7,498,8450-5,478,625-10,339,926-13,766,483-15,031,095-23,367,245-35,902,972-42,030,000-26,583,000-25,142,000-26,665,000-35,381,000-61,845,000-48,587,000
CFO
-31m
L-36.26%
-8,300,917-3,443,062-4,318,025-1,688,546-2,693,795-4,346,960-8,039,010-6,755,570-7,017,968-7,300,956-8,426,790-12,955,454-27,532,954-22,747,000-25,901,000-18,037,000-19,090,000-38,011,000-48,939,000-31,195,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

Key people

James Corbett
President, Chief Executive Officer, Executive Director · since 2022
David O'Toole
Chief Financial Officer · since 2023
Nicole Kelsey
Chief Legal and Compliance Officer, Corporate Secretary · since 2024
Joseph Woody
Non-Executive Director · since 2026
Michael Tarnoff
Independent Director · since 2025
Jeremy Cook
Independent Non-Executive Director · since 2015
Suzanne Crowe
Independent Non-Executive Director · since 2016
Robert Mcnamara
Independent Non-Executive Director · since 2023
Jan Reed
Independent Non-Executive Director · since 2021
Cary Vance
Independent Non-Executive Director · since 2023
URL
https://www.avitamedical.com/
IPO date
Mar 18, 2012
Employees
126
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT